Clinical Trial Update: A Trial of Two Fixed Doses of ZX008 (Fenfluramine HCl) in Children and Young Adults With Dravet Syndrome [Phase 3]

View source ↗

Summary

Phase 3 trial of two fixed doses of fenfluramine (ZX008) in children and young adults with Dravet syndrome has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dravet Syndrome
• Seizure Disorder

Drugs mentioned

• ZX008 (fenfluramine hydrochloride)

Snippet

Sponsor: Zogenix International Limited, Inc., a subsidiary of Zogenix, Inc. | Conditions: Dravet Syndrome, Seizure Disorder | Phase 3 | Status: COMPLETED | Results posted: 2022-10-19